Sage Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	220,921	223,396	106,851	31,326	26,263	7,753	Upgrade
Market Cap Growth	109.07%	109.07%	241.10%	19.28%	238.75%	413.82%	Upgrade
Enterprise Value	217,489	217,201	108,548	33,643	27,973	9,199	Upgrade
Last Close Price	14743.65	14908.85	7399.20	2340.85	2012.33	594.04	Upgrade
PE Ratio	362.06	366.11	253.11	121.35	205.00	178.02	Upgrade
PS Ratio	71.71	72.51	41.60	14.29	14.63	4.75	Upgrade
PB Ratio	15.93	16.11	16.55	10.22	15.58	4.99	Upgrade
P/TBV Ratio	16.71	16.90	16.57	10.24	15.65	5.02	Upgrade
P/OCF Ratio	1626.10	1644.32	-	66.94	105.69	187.61	Upgrade
EV/Sales Ratio	70.60	70.50	42.26	15.34	15.58	5.63	Upgrade
EV/EBITDA Ratio	299.97	299.57	147.10	56.44	64.37	25.30	Upgrade
EV/EBIT Ratio	-	402.55	189.36	77.95	96.35	41.54	Upgrade
EV/FCF Ratio	-123.29	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.04	0.04	0.28	0.58	1.16	1.17	Upgrade
Debt / EBITDA Ratio	0.84	0.84	2.46	2.96	4.52	4.98	Upgrade
Asset Turnover	0.25	0.25	0.36	0.45	0.44	0.44	Upgrade
Inventory Turnover	0.38	0.38	0.81	0.76	0.74	0.79	Upgrade
Quick Ratio	4.49	4.49	2.12	0.79	0.51	0.58	Upgrade
Current Ratio	6.77	6.77	2.91	1.60	1.11	1.13	Upgrade
Return on Equity (ROE)	6.00%	6.00%	8.87%	10.87%	7.91%	2.85%	Upgrade
Return on Assets (ROA)	2.72%	2.72%	4.95%	5.51%	4.41%	3.68%	Upgrade
Return on Capital (ROIC)	2.96%	2.96%	5.47%	6.36%	5.18%	4.33%	Upgrade
Return on Capital Employed (ROCE)	3.70%	3.70%	7.60%	10.00%	10.10%	8.10%	Upgrade
Earnings Yield	0.28%	0.27%	0.40%	0.82%	0.49%	0.56%	Upgrade
FCF Yield	-0.80%	-0.79%	-1.99%	-1.58%	-0.13%	-2.80%	Upgrade
Buyback Yield / Dilution	-6.14%	-6.14%	-5.28%	-151.99%	-0.08%	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.